CEG — Claude Opus 4.8

I'll research CEG (Constellation Energy) before writing the preview. Let me gather recent earnings, filings, and news.Let me gather recent news and stock price context, plus the year-ago Q2 figures for comparison.Let me get consensus estimates and recent developments via web search.# Constellation Energy (CEG) — Q2 2026 Earnings Preview

Reports before market open, Thursday, August 6, 2026 (10:00 a.m. ET call)

The One-Line Setup

CEG heads into its first "clean" post-Calpine summer quarter with a beaten-down stock (down ~28% YTD), a full-year guide it has so far only affirmed, and a market that increasingly wants two things: (1) evidence the Calpine deal is compounding as promised, and (2) a big, signed nuclear data-center deal — most likely Calvert Cliffs/Amazon — to re-rate the story. This is more of an "unlock the catalysts" quarter than a pure EPS-beat quarter.

What the Numbers Should Look Like

Metric	Consensus / Guide	Comparison
Q2 2026 adj. EPS	~$2.24–$2.35 (Street clustered ~$2.3)	vs. $1.91 in Q2'25 (+~20%)
FY 2026 adj. EPS guidance	$11.00–$12.00 (affirmed at Q1)	Street ~$11.74 (near upper half)
FY 2026 revenue (Street)	~$35.5B	vs. FY'25 (+~39%, Calpine-driven)
Q1 2026 actual (context)	adj. $2.74 (GAAP $4.49)	vs. $2.14 in Q1'25

Key caveat on comps: Year-over-year comparisons are noisy. Q2'25's $1.91 was a pre-Calpine number, and the FY guide jumped from FY'25's $8.90–$9.60 to $11–$12 largely because of Calpine accretion (~$2/share full-year) plus stronger PJM capacity prices. Focus on guidance trajectory and segment drivers rather than optical YoY growth.

The Five Things That Actually Matter

1. Does guidance move toward the upper half — or up?

At Q1, management affirmed $11–$12 and Dominguez explicitly said he'd want "at least another quarter" before gaining confidence in the upper half. Q2 is that quarter. With Q1 at $2.74 and ~$2.3 expected in Q2, the first-half run-rate (~$5.0) tracks comfortably inside the range. Watch for: language nudging toward the top half, and any raise. A simple re-affirm with the stock this depressed could disappoint.

2. Calpine integration, synergies, and the lock-up overhang

This is the first full quarter with Calpine fully in the run-rate. Watch for: - Synergy/integration progress and merger-cost cadence (Calpine merger/integration costs were a $0.34 non-GAAP add-back in Q1). - Gas/thermal fleet performance — new metric EFOF (4.5% in Q1); CCGT+cogen ran a ~47% capacity factor / ~5% forced-outage factor. Summer is prime dispatch season, so utilization and spark spreads matter here. - Share overhang: The first Calpine lock-up (25M of the 50M shares issued) expired June 30, 2026; the remaining 25M frees up June 30, 2027. Management sized the $5B buyback partly to absorb potential selling — expect a question on whether a block/secondary transaction materialized.

3. Data-center / "Powered Land" deals — the real catalyst

The market is waiting on a marquee nuclear PPA. Watch specifically: - Calvert Cliffs / Amazon — widely reported (since the March business update) that Amazon wants large data-center campuses at the site. A signed deal here would be the single biggest potential re-rating event. - CyrusOne / Freestone (ERCOT): 380 MW Phase 1 substation under construction, expected to energize in Q4 2026, plus an exclusive 380 MW Phase 2. Look for schedule confirmation. - ~5,000 MW of new capacity (nuclear uprates, new gas, batteries) submitted into PJM's queue as contract-ready supply. - Precedent: Clinton/Meta 20-year PPA (starts June 2027). Any similar-scale nuclear offtake announcement is the upside lever.

4. PJM regulatory clarity (the gating item) + the capacity auction print

Regulatory framework: At Q1, Dominguez said PJM aimed to submit its large-load "backstop" and co-location framework to FERC around June, and expected clarity "by the end of the year." An update on where FERC/PJM landed, and whether the 2029 co-location implementation date got pulled forward, is critical — this is what's pausing some hyperscaler contracts.
Capacity auction (already out): On July 14, 2026, CEG disclosed it cleared 18,875 MW in the PJM 2028/29 base residual auction (up from 17,950 MW), at prices that reportedly hit the ~$325 price cap, implying ~$2.2B of capacity revenue for that delivery year. This is a known tailwind feeding the out-year outlook — expect it framed as supporting the >20% base EPS growth-through-2029 narrative.

5. Crane (ex-TMI) restart + nuclear uprates

Crane Clean Energy Center: on track to return to service in 2027 (ahead of original schedule). The live issue is the CIR transfer from Eddystone filed at FERC to secure a 2027 capacity credit — management expected a FERC response in the June/July window, so an update is likely.
Uprates: Byron and Braidwood are in-plan; other uprate capital is being spent but EPS accretion isn't modeled until ~2030. Watch for any pull-forward.

Capital Allocation & Cash

Management leaned hard into the FCF story last quarter: ~$8.4B FCF-before-growth for 2026–27, rising to $11.5–$13B for 2028–29. Framework = investment-grade metrics, 10%/yr dividend growth, double-digit-return organic investment, and opportunistic buybacks. In April/May they bought ~1.2M shares at ~$285 ($335M) under the $5B authorization. With the stock now in the $260s, watch for a more aggressive buyback pace — and note management framed ~$285 as "compelling," so ~$265 should be even more so.

Sentiment / Stock Context

Price action: CEG opened 2026 at ~$366 and sits at ~$265 (Aug 5) — down roughly 28% YTD, and having bounced off a July low near $236. Peer Vistra (VST) has followed a similar down-then-stabilize path.
Sell-side trims: In late July, several shops cut targets while staying constructive — UBS to $380, BMO to $376, BofA to $341 — with the MarketBeat consensus target still well above spot (~$360). The gap between targets and price signals the Street sees value but wants catalysts.
Why the derate: softer ERCOT forward power curves (management called ERCOT out-years "undervalued"), the PJM regulatory limbo delaying contract signings, and the Calpine share overhang. A print that de-risks any of these could move the stock meaningfully.

Other Notes

Governance: On Aug 5, CEG named CEO Joe Dominguez Board Chair and appointed a Lead Independent Director — a governance item, not a fundamental driver, but expect it acknowledged.
Weather/one-timers: Q1 carried a modest drag from Winter Storm Fern (ancillary/reserve costs). Summer heat and any nuclear/thermal outage days are the Q2 swing factors — note Q2'25 had an elevated 22 non-refueling outage days, so the outage comp is favorable if the fleet ran clean.

Bottom Line — What to Listen For

Guidance tone — affirm vs. lean-to-upper-half vs. raise.
A named nuclear data-center deal (Calvert Cliffs is the one to watch) — the biggest potential upside surprise.
PJM/FERC framework status — the key that unlocks paused hyperscaler contracts.
Buyback pace at a depressed stock price, and any color on the June 30 Calpine lock-up.
Calpine run-rate execution — synergies, gas-fleet summer utilization, and integration-cost tail.

Given the affirmed guide and improving first-half run-rate, the EPS print itself is likely a low-drama beat-or-meet; the share reaction should hinge far more on the commercial (data-center) and regulatory (PJM) catalysts than on the quarter's cents.

Note: I could not retrieve a fully consolidated third-party consensus for Q2; figures above (~$2.24–$2.35 EPS, ~$11.74 FY, ~$360 avg. target) are drawn from recent public estimate aggregators and should be validated against your own consensus feed before the print.